Russian Pharmaceutical Industry Leader

About Pharmasyntez

The Pharmasyntez group
The leading producer of socially important drugs in Russia
  • Our specialization is development and production of antitubercular, antineoplastic, antiretroviral medicines, and hospital antibiotics
  • Product portfolio - more than 300 types of drugs and over 60 types of pharmaceutical substances
  • We produce medicines in all dosage forms: tablets, capsules, granules, infusion solutions, sterile powders, injectables
  • Our five high-technology factories are the powerful modern production base
  • We produce the high-quality and effective medicines demanded by modern medicine
  • We develop innovative medicines
  • We increase the share of domestic drugs in the Russian market due to replacement of the imported substitute products
Technologies and quality
We guarantee steadily high quality of the produced drugs which is based on:
  • modern high-technology equipment
  • compliance with the GMP standards
  • high qualified personnel
Production capacities

The production capacities of the Pharmasyntez Group are represented by five modern factories in Irkutsk, St. Petersburg, Ussuriysk, Bratsk, and Tyumen. High-tech complexes are built in accordance with international GMP quality standards and are equipped with the most modern production and analytical equipment from the world's leading manufacturers. This guarantees consistently high quality and effectiveness of the products produced.

Annual production is more than 87 million packs
Pharmasyntez is the leader in hospital deliveries

The medicines made in Russia constitute 72.8% in a segment of the public hospital procurements, which remains 33.5% in nowadays value.

Effective business

The main goal of the company is to form a reliable long-term partner relationships. We highly respect the principles of legality, conscientiousness, professionalism. These are the basis of effective and mutually beneficial cooperation both with Russian and the foreign pharmaceutical companies.

  • Effective business processes in construction
  • Experience in production sites creation
  • Advanced technologies in production and management
  • Wide experience in medicines registration
  • Representatives in all regions of Russia
  • Highly-developed distributor network – more than 50 traders are presenting company’s products at the Russian market and in the CIS countries
  • Own system of medicines promotion in the market
  • Original incentive system of sales
Research center
  • Transfer of technologies and establishing production of generics on own production sites
  • Development of original production technologies
  • Research, development of original medicines and deployment in medical practice
  • Powerful research base
  • Annual investments in development of innovative medicines - up to 500 million rubles
Responsible employer
Professional orientation work with school students and students of higher education institutions
  • Competitive candidates screen for target training
  • Training at the expense of the company
  • Target grants
  • Guaranteed employment
System work on advanced training of a personnel:
  • Annually more than 60 employees are trained
  • Annual investments in personnel development are more than 1 million rubles
People care
  • The staff is provided with sanatorium and rehabilitation and recovery treatment by VHI and according to the results of the performed medical examinations
  • There is a big dining hall opened in 2017 which operates during the complete working cycle and completely corresponds to the production schedule of the plant. At the same time, the company partially covers employees’ expenses on food.
  • There have been created more than 300 new workplaces for the last three years
  • The average monthly salary level is 36 thousand rubles